SCHEMBL30808596

SCHEMBL30808596

O=C(O)CN1C(=O)CSc2ccc(F)cc21

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TSHR P16473 1/20 0.48
MEN1 O00255 1/20 0.48
GSK3A P49840 1/20 0.48
GSK3B P49841 1/20 0.48
KMT2A Q03164 1/20 0.48
TP53 P04637 4/20 0.47
MAPT P10636 2/20 0.46
NPSR1 Q6W5P4 1/20 0.45
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10649933 1.00 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL10648891 0.89 TSHR (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL10653259 0.85 MEN1 (0.40) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL30808645 0.83 LMNA (0.54) ALDH1A1MEN1GSK3AGSK3BKMT2A
SCHEMBL10509738 0.83 LMNA (0.54) ALDH1A1MEN1GSK3AGSK3BKMT2A
SCHEMBL30808603 0.83 MEN1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL10511510 0.83 ALDH1A1 (0.56) ALDH1A1MEN1GSK3AGSK3BKMT2A
SCHEMBL10650996 0.82 NPSR1 (0.70) ALDH1A1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL10511825 0.80 LMNA (0.51) MEN1KMT2AMAPTNPSR1LMNA
SCHEMBL30808619 0.80 NPSR1 (0.67) ALDH1A1TSHRMEN1GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250002-A1 IDENTIFICATION OF NOVEL BENZOTHIAZONES AS TAU-SH3 INTERACTION INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE SOUTHERN RESEARCH INSTITUTE (US) 2023-12-28 WO disclosed